Nigerian-Lebanese tycoon Bassim Haidar’s Optasia targets $1.5 billion valuation in Johannesburg IPO
Optasia, led by Nigerian-Lebanese tycoon Bassim Haidar, plans a Johannesburg IPO targeting a $1.5 billion valuation.
Skip to content
Optasia, led by Nigerian-Lebanese tycoon Bassim Haidar, plans a Johannesburg IPO targeting a $1.5 billion valuation.
Stephen Saad’s Aspen Pharmacare stake drops by $20 million as the company’s stock slips 6 percent on the Johannesburg Stock Exchange (JSE).
Oando, led by Wale Tinubu, issues 679 million bonus shares, rewarding investors with 8.3% amid Nigeria’s oil market challenges.
Gus Attridge’s Aspen Pharmacare stake drops over $12 million as shares slide 9.45%, pushing market value below $3 billion.
Pick n Pay’s recent rally lifts Ackerman family’s stake above $185 million, reversing May losses.
According to Forbes estimates, his net worth rose from $3 billion in mid-March to $3.2 billion by late May.
The lawsuit threatens to derail ARC’s plans to delist and restructure, casting a shadow over the firm’s future.
The decline reflects growing pressure on retail stocks in South Africa, as investor sentiment shifts on the Johannesburg Stock Exchange.
Tencent’s struggles and global tech uncertainty weigh on Africa’s most valuable company, Naspers.
The family’s stake, previously valued at R4 billion ($213.8 million), now stands at R3.62 billion ($193.95 million).
The recent decline, however, reflects a shift in investor sentiment, despite Discovery's robust financial results.
Discount grocery chain Boxer to launch IPO on Johannesburg Stock Exchange, aiming to raise substantial capital for expansion.
Earlier, between Sept. 6 and 19, his stake increased by R1.68 billion ($95.3 million), lifting the value from R37.94 billion ($2.16 billion) to R39.62 billion ($2.26 billion).
South African billionaire Christo Wiese’s stake in Shoprite has increased by $115.84 million, strengthening his position among Africa’s wealthiest.
South African pharma mogul Gus Attridge loses $16.5 million from stake in Africa’s largest pharmaceutical company.
Stephen Brookes sees his Balwin Properties stake rise above $20 million amid a rally in the company's shares on the JSE.